Inhaler showdown: which device tames asthma best?

NCT ID NCT07372573

Not yet recruiting Symptom relief Sponsor: University of Health Sciences Lahore Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two types of inhalers—pressurized metered dose inhalers (pMDI) and dry powder inhalers (DPI)—to see which delivers asthma medication more effectively. Researchers will enroll 210 patients with uncontrolled asthma and measure changes in symptom control after 8 weeks. The goal is to find out if the device itself makes a difference in how well the medicine works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: budesonide/formoterol (inhaled corticosteroid and long-acting beta agonist)
What this could lead to: If this trial shows one device works better, it could help doctors choose the right inhaler for better asthma control.
What could go wrong: This is a small, early-stage study that hasn't started yet. Results may not apply to all asthma patients, and device preference can vary individually.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA (DIAGNOSIS)

Contacts and locations

Locations

Services Hospital Lahore

Lahore, Punjab Province, 54000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.